SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) announced that CFO Ross Muken will participate in the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference in Boston on May 24, 2022. The company's management will also engage in multiple investor meetings during the event. SOPHiA GENETICS is committed to advancing data-driven medicine through its innovative SOPHiA DDM™ Platform, which is utilized by over 790 healthcare institutions globally. For investor inquiries, contact Jennifer Pottage, Head of Investor Relations.

BOSTON and LAUSANNE, Switzerland, April 27, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced CFO, Ross Muken will attend the upcoming J.P. Morgan 50^th Annual Global Technology, Media, and Communications Conference in Boston, Massachusetts on May 24. Management and IR will also host several meetings with investors at the conference. To coordinate a meeting, please contact Jennifer Pottage, Head of Investor Relations at jpottage@sophiagenetics.com.

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by over 790 hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram. Where others see data, we see answers.

Investor Contact:
Jennifer Pottage
Head of Investor Relations
Jpottage@sophiagenetics.com

Media Contact:
Eliza Bamonti
Director of Public Relations
Ebamonti@sophiagenetics.com

FAQ

What is the date of SOPHiA GENETICS' participation in the J.P. Morgan conference?

SOPHiA GENETICS will participate in the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference on May 24, 2022.

Who from SOPHiA GENETICS will attend the J.P. Morgan conference?

CFO Ross Muken will attend the J.P. Morgan conference.

How can investors meet with SOPHiA GENETICS at the conference?

Investors can coordinate meetings with SOPHiA GENETICS by contacting Jennifer Pottage, Head of Investor Relations.

What does SOPHiA GENETICS specialize in?

SOPHiA GENETICS specializes in data-driven medicine and operates the SOPHiA DDM™ Platform for analyzing complex data sets.

How many institutions use SOPHiA GENETICS' platform globally?

The SOPHiA DDM™ Platform is used by over 790 hospitals, laboratories, and biopharma institutions worldwide.